Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination

Cell Cycle

Volumn 12, Issue 5, 2013, Pages 762-772

  Lackey, Lela ^a,b   Law, Emily K ^a,b   Brown, William L ^a,b   Harris, Reuben S ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

APOBEC3; Cancer; Cell cycle; DNA cytosine deamination; Mitosis; Subcellular localization; Uracil

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CELL PROTEIN; DEAMINASE; GENOMIC DNA; NUCLEAR PROTEIN; PROTEIN APOBEC3; PROTEIN APOBEC3A; PROTEIN APOBEC3B; PROTEIN APOBEC3D; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE PHASE; CELLULAR DISTRIBUTION; CHROMATIN; CHROMOSOME; CONTROLLED STUDY; DEAMINATION; DNA DAMAGE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOSIS; PROTEIN LOCALIZATION; TELOPHASE;

EID: 84874624527     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23713     Document Type: Article

References (75)

1. Conticello SG. The AID/APOBEC family of nucleic acid mutators. Genome Biol 2008; 9:229; PMID:18598372; http://dx.doi.org/10.1186/gb-008-9-6-229
2. Albin JS, Harris RS. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Rev Mol Med 2010; 12:e4; PMID:20096141; http://dx.doi.org/10.1017/S1462399409001343
3. Larue RS, Lengyel J, Jónsson SR, Andrésdóttir V, Harris RS. Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity. J Virol 2010; 84:8193-201; PMID:20519393; http://dx.doi.org/10.1128/JVI.00685-10
4. Malim MH, Emerman M. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 2008; 3:388-98; PMID:18541215; http://dx.doi.org/10.1016/j.chom.2008.04.008
5. Aguiar RS, Peterlin BM. APOBEC3 proteins and reverse transcription. Virus Res 2008; 134:74-85; PMID:18262674; http://dx.doi.org/10.1016/j. virusres.2007.12.022
6. Hultquist JF, Lengyel JA, Refsland EW, LaRue RS, Lackey L, Brown WL, et al. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J Virol 2011; 85:11220-34; PMID:21835787; http://dx.doi.org/10.1128/JVI.05238-11
7. Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med 2003; 197:1173-81; PMID:12732658; http://dx.doi.org/10.1084/jem.20030275
8. Pasqualucci L, Bhagat G, Jankovic M, Compagno M, Smith P, Muramatsu M, et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet 2008; 40:108-12; PMID:18066064; http://dx.doi. org/10.1038/ng.2007.35
9. Robbiani DF, Bothmer A, Callen E, Reina-San-Martin B, Dorsett Y, Difilippantonio S, et al. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 2008; 135:1028-38; PMID:19070574; http://dx.doi.org/10.1016/j. cell.2008.09.062
10. Nakamuta M, Chang BH, Zsigmond E, Kobayashi K, Lei H, Ishida BY, et al. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1. J Biol Chem 1996; 271:25981-8; PMID:8824235; http://dx.doi.org/10. 1074/jbc.271.42.25981
11. Yamanaka S, Balestra ME, Ferrell LD, Fan J, Arnold KS, Taylor S, et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci USA 1995; 92:8483-7; PMID:7667315; http://dx.doi. org/10.1073/pnas.92.18.8483
12. Suspène R, Aynaud MM, Guétard D, Henry M, Eckhoff G, Marchio A, et al. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci USA 2011; 108:4858-63; PMID:21368204; http://dx.doi.org/10.1073/pnas.1009687108
13. Landry S, Narvaiza I, Linfesty DC, Weitzman MD. APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. EMBO Rep 2011; 12:444-50; PMID:21460793; http://dx.doi.org/10.1038/embor.2011.46
14. Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 2013; PMID:23389445; http://dx.doi.org/10.1038/nature11881
15. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391:43-50; PMID:9422506; http://dx.doi.org/10.1038/34112
16. Reich NC, Liu L. Tracking STAT nuclear traffic. Nat Rev Immunol 2006; 6:602-12; PMID:16868551; http://dx.doi.org/10.1038/nri1885
17. Pelzer C, Thome M. IKKα takes control of canonical NF-κB activation. Nat Immunol 2011; 12:815-6; PMID:21852778; http://dx.doi.org/10. 1038/ni.2082
18. Yoneda Y. Nucleocytoplasmic protein traffic and its significance to cell function. Genes Cells 2000; 5:777-87; PMID:11029654; http://dx.doi.org/10.1046/ j.1365-2443.2000.00366.x
19. Güttinger S, Laurell E, Kutay U. Orchestrating nuclear envelope disassembly and reassembly during mitosis. Nat Rev Mol Cell Biol 2009; 10:178-91; PMID:19234477; http://dx.doi.org/10.1038/nrm2641
20. Estrada-Gelonch A, Aramburu J, López-Rodríguez C. Exclusion of NFAT5 from mitotic chromatin resets its nucleo-cytoplasmic distribution in interphase. PLoS ONE 2009; 4:e7036; PMID:19750013; http://dx.doi. org/10.1371/journal.pone.0007036
21. Zaidi SK, Young DW, Pockwinse SM, Javed A, Lian JB, Stein JL, et al. Mitotic partitioning and selective reorganization of tissue-specific transcription factors in progeny cells. Proc Natl Acad Sci USA 2003; 100:14852-7; PMID:14657346; http://dx.doi. org/10.1073/pnas.2533076100
22. Niewiadomska AM, Tian C, Tan L, Wang T, Sarkis PT, Yu XF. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with highmolecular-mass-complex formation or P-body association. J Virol 2007; 81:9577-83; PMID:17582006; http://dx.doi.org/10.1128/JVI.02800-06
23. Kinomoto M, Kanno T, Shimura M, Ishizaka Y, Kojima A, Kurata T, et al. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res 2007; 35:2955-64; PMID:17439959; http://dx.doi.org/10.1093/ nar/gkm181
24. Marin M, Golem S, Rose KM, Kozak SL, Kabat D. Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism. J Virol 2008; 82:987-98; PMID:17977970; http://dx.doi.org/10.1128/JVI.01078-07
25. Muckenfuss H, Hamdorf M, Held U, Perkovic M, Löwer J, Cichutek K, et al. APOBEC3 proteins inhibit human LINE-1 retrotransposition. J Biol Chem 2006; 281:22161-72; PMID:16735504; http://dx.doi. org/10.1074/jbc.M601716200
26. Chen H, Lilley CE, Yu Q, Lee DV, Chou J, Narvaiza I, et al. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr Biol 2006; 16:480-5; PMID:16527742; http://dx.doi. org/10.1016/j.cub.2006.01.031
27. Goila-Gaur R, Khan MA, Miyagi E, Kao S, Strebel K. Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity. Retrovirology 2007; 4:61; PMID:17727729; http://dx.doi.org/10.1186/1742-4690-4-61
28. Bogerd HP, Wiegand HL, Doehle BP, Lueders KK, Cullen BR. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res 2006; 34:89-95; PMID:16407327; http://dx.doi.org/10.1093/nar/ gkj416
29. OhAinle M, Kerns JA, Li MM, Malik HS, Emerman M. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 2008; 4:249-59; PMID:18779051; http://dx.doi. org/10.1016/j.chom.2008.07.005
30. Lackey L, Demorest ZL, Land AM, Hultquist JF, Brown WL, Harris RS. APOBEC3B and AID have similar nuclear import mechanisms. J Mol Biol 2012; 419:301-14; PMID:22446380; http://dx.doi. org/10.1016/j.jmb.2012.03.011
31. Patenaude AM, Orthwein A, Hu Y, Campo VA, Kavli B, Buschiazzo A, et al. Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat Struct Mol Biol 2009; 16:517-27; PMID:19412186; http://dx.doi.org/10.1038/ nsmb.1598
32. McBride KM, Barreto V, Ramiro AR, Stavropoulos P, Nussenzweig MC. Somatic hypermutation is limited by CRM1-dependent nuclear export of activationinduced deaminase. J Exp Med 2004; 199:1235-44; PMID:15117971; http://dx.doi.org/10. 1084/jem.20040373
33. Ito S, Nagaoka H, Shinkura R, Begum N, Muramatsu M, Nakata M, et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc Natl Acad Sci USA 2004; 101:1975-80; PMID:14769937; http://dx.doi.org/10.1073/pnas.0307335101
34. Yang Y, Sowden MP, Yang Y, Smith HC. Intracellular trafficking determinants in APOBEC-1, the catalytic subunit for cytidine to uridine editing of apolipoprotein B mRNA. Exp Cell Res 2001; 267:153-64; PMID:11426934; http://dx.doi.org/10.1006/excr.2001.5255
35. Blanc V, Kennedy S, Davidson NO. A novel nuclear localization signal in the auxiliary domain of apobec-1 complementation factor regulates nucleocytoplasmic import and shuttling. J Biol Chem 2003; 278:41198-204; PMID:12896982; http://dx.doi.org/10.1074/jbc. M302951200
36. Blanc V, Henderson JO, Kennedy S, Davidson NO. Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity. J Biol Chem 2001; 276:46386-93; PMID:11571303; http://dx.doi. org/10.1074/jbc.M107654200
37. Bennett RP, Presnyak V, Wedekind JE, Smith HC. Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding. J Biol Chem 2008; 283:7320-7; PMID:18165230; http://dx.doi.org/10.1074/jbc.M708567200
38. Stenglein MD, Harris RS. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J Biol Chem 2006; 281:16837-41; PMID:16648136; http://dx.doi. org/10.1074/jbc.M602367200
39. Stenglein MD, Matsuo H, Harris RS. Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization. J Virol 2008; 82:9591-9; PMID:18667511; http://dx.doi. org/10.1128/JVI.02471-07
40. Wichroski MJ, Robb GB, Rana TM. Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies. PLoS Pathog 2006; 2:e41; PMID:16699599; http://dx.doi.org/10.1371/journal.ppat.0020041
41. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003; 424:99-103; PMID:12808466; http://dx.doi.org/10.1038/nature01709
42. Gallois-Montbrun S, Holmes RK, Swanson CM, Fernández-Ocaña M, Byers HL, Ward MA, et al. Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins. J Virol 2008; 82:5636-42; PMID:18367521; http://dx.doi.org/10.1128/JVI.00287-08
43. Gallois-Montbrun S, Kramer B, Swanson CM, Byers H, Lynham S, Ward M, et al. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol 2007; 81:2165-78; PMID:17166910; http://dx.doi. org/10.1128/JVI.02287-06
44. Bonvin M, Achermann F, Greeve I, Stroka D, Keogh A, Inderbitzin D, et al. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 2006; 43:1364-74; PMID:16729314; http://dx.doi. org/10.1002/hep.21187
45. Nowarski R, Wilner OI, Cheshin O, Shahar OD, Kenig E, Baraz L, et al. APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair. Blood 2012; 120:366-75; PMID:22645179; http://dx.doi.org/10.1182/blood-2012-01-402123
46. Brar SS, Watson M, Diaz M. Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J Biol Chem 2004; 279:26395-401; PMID:15087440; http://dx.doi.org/10. 1074/jbc.M403503200
47. Pak V, Heidecker G, Pathak VK, Derse D. The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B. J Virol 2011; 85:8538-47; PMID:21715505; http://dx.doi. org/10.1128/JVI.02645-10
48. OhAinle M, Kerns JA, Malik HS, Emerman M. Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. J Virol 2006; 80:3853-62; PMID:16571802; http://dx.doi.org/10.1128/JVI.80.8.3853- 3862.2006
49. Wang X, Abudu A, Son S, Dang Y, Venta PJ, Zheng YH. Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity. J Virol 2011; 85:3142-52; PMID:21270145; http://dx.doi.org/10.1128/JVI.02049-10
50. Martin RM, Cardoso MC. Chromatin condensation modulates access and binding of nuclear proteins. FASEB J 2010; 24:1066-72; PMID:19897663; http://dx.doi.org/10.1096/fj.08-128959
51. Wolff B, Sanglier JJ, Wang Y. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem Biol 1997; 4:139-47; PMID:9190288; http://dx.doi.org/10.1016/S1074-5521(97) 90257-X
52. Harper JV. Synchronization of cell populations in G1/S and G2/M phases of the cell cycle. Methods Mol Biol 2005; 296:157-66; PMID:15576930
53. Hasham MG, Donghia NM, Coffey E, Maynard J, Snow KJ, Ames J, et al. Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination. Nat Immunol 2010; 11:820-6; PMID:20657597; http://dx.doi.org/10.1038/ni.1909
54. Chen KM, Harjes E, Gross PJ, Fahmy A, Lu Y, Shindo K, et al. Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G. Nature 2008; 452:116-9; PMID:18288108; http://dx.doi. org/10.1038/nature06638
55. Chelico L, Pham P, Calabrese P, Goodman MF. APOBEC3G DNA deaminase acts processively 3'->5' on single-stranded DNA. Nat Struct Mol Biol 2006; 13:392-9; PMID:16622407; http://dx.doi. org/10.1038/nsmb1086
56. LaRue RS, Jónsson SR, Silverstein KA, Lajoie M, Bertrand D, El-Mabrouk N, et al. The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol Biol 2008; 9:104; PMID:19017397; http://dx.doi. org/10.1186/1471-2199-9-104
57. Jónsson SR, Haché G, Stenglein MD, Fahrenkrug SC, Andrésdóttir V, Harris RS. Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins. Nucleic Acids Res 2006; 34:5683-94; PMID:17038330; http://dx.doi. org/10.1093/nar/gkl721
58. Lassen KG, Wissing S, Lobritz MA, Santiago M, Greene WC. Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif. J Biol Chem 2010; 285:29326-35; PMID:20624919; http://dx.doi.org/10.1074/jbc. M110.154054
59. Schrader CE, Guikema JE, Linehan EK, Selsing E, Stavnezer J. Activation-induced cytidine deaminasedependent DNA breaks in class switch recombination occur during G1 phase of the cell cycle and depend upon mismatch repair. J Immunol 2007; 179:6064-71; PMID:17947680
60. Stenglein MD, Burns MB, Li M, Lengyel J, Harris RS. APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol 2010; 17:222-9; PMID:20062055; http://dx.doi. org/10.1038/nsmb.1744
61. Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res 2010; 38:4274-84; PMID:20308164; http://dx.doi.org/10.1093/nar/gkq174
62. Koning FA, Newman EN, Kim EY, Kunstman KJ, Wolinsky SM, Malim MH. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol 2009; 83:9474-85; PMID:19587057; http://dx.doi.org/10.1128/JVI. 01089-09
63. Kidd JM, Newman TL, Tuzun E, Kaul R, Eichler EE. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet 2007; 3:e63; PMID:17447845; http://dx.doi.org/10.1371/journal. pgen.0030063
64. Duggal NK, Malik HS, Emerman M. The breadth of antiviral activity of Apobec3DE in chimpanzees has been driven by positive selection. J Virol 2011; 85:11361-71; PMID:21835794; http://dx.doi. org/10.1128/JVI.05046-11
65. Dang Y, Abudu A, Son S, Harjes E, Spearman P, Matsuo H, et al. Identification of a single amino acid required for APOBEC3 antiretroviral cytidine deaminase activity. J Virol 2011; 85:5691-5; PMID:21430060; http://dx.doi.org/10.1128/JVI.00243-11
66. Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M, et al. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 2004; 118:431-8; PMID:15315756; http://dx.doi. org/10.1016/j.cell. 2004.08.006
67. Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, et al.; Breast Cancer Working Group of the International Cancer Genome Consortium. Mutational processes molding the genomes of 21 breast cancers. Cell 2012; 149:979-93; PMID:22608084; http://dx.doi.org/10.1016/j. cell.2012.04.024
68. Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, et al.; Oslo Breast Cancer Consortium (OSBREAC). The landscape of cancer genes and mutational processes in breast cancer. Nature 2012; 486:400-4; PMID:22722201
69. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446:153-8; PMID:17344846; http://dx.doi.org/10.1038/nature05610
70. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011; 333:1154-7; PMID:21798897; http://dx.doi.org/10.1126/science. 1206923
71. Jones S, Wang TL, Shih IeM, Mao TL, Nakayama K, Roden R, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010; 330:228-31; PMID:20826764; http://dx.doi.org/10.1126/science. 1196333
72. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467:1114-7; PMID:20981102; http://dx.doi.org/10.1038/nature09515
73. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, et al. The genomic complexity of primary human prostate cancer. Nature 2011; 470:214-20; PMID:21307934; http://dx.doi. org/10.1038/nature09744
74. Carpenter MA, Li M, Rathore A, Lackey L, Law EK, Land AM, et al. Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A. J Biol Chem 2012; 287:34801-8; PMID:22896697; http://dx.doi.org/10.1074/jbc. M112.385161
75. Demorest ZL, Li M, Harris RS. Phosphorylation directly regulates the intrinsic DNA cytidine deaminase activity of activation-induced deaminase and APOBEC3G protein. J Biol Chem 2011; 286:26568-75; PMID:21659520; http://dx.doi.org/10.1074/jbc. M111.235721